tirzepatide semaglutide weight loss comparison vs for Treatment The Difference Between Semaglutide and

In this trial, three doses of tirzepatide (5 mg, 10 mg and 15 mg once weekly) were compared with placebo in individuals with overweight (BMI 27 kg/m 2 ) and complications, or with obesity (BMI 30 kg/m 2 )

At maximum doses, the two medications now produce very similar results: Wegovy 7.2 mg: 20.7% average weight loss (STEP UP trial) 2 Mounjaro 15 mg: 20.2% average weight loss (SURMOUNT-5 trial) 1 This means that if maximum weight loss is your primary goal, both medications can now achieve comparable results when used at their highest doses

Your address can be updated from the Shipping tab of your account

Users consistently praise the speed of onboarding, with some receiving prescriptions on the same day they signed up

Here is a table outlining the key differences: Potential advantages of stimulating vs